Metodbevispost

Phase II clinical trial

A Phase II clinical trial is the second stage in the drug or intervention development pipeline, conducted after Phase I safety testing. Its primary goal is to assess whether the intervention shows preliminary efficacy signals in a relevant patient population at the dose established in Phase I, while continuing to characterise the safety and tolerability profile. Phase II trials are generally smaller than Phase III confirmatory trials and serve as critical go/no-go decision points before large-scale investment.

Sources recorded, not reviewed

Källpost

Citat kopierade ordagrant från metodens källpost. Ingen verifiering på källnivå härleds från dem.

Phase II Clinical Trial

Taxonomisk metodpost · process-pipeline / epidemiology

Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015). Fundamentals of Clinical Trials (5th ed.). Springer. · ISBN 978-3319185392
Phase II clinical trial. Wikipedia. · URL

Öppna fullständig metod

Kuraterade påståenden

Påståenden lagrade i bevisloggen, var och en med sin egen bedömning.

Inga kuraterade påståenden ännu

Denna vy hittar inte på en påståendebedömning när loggen saknar en.

Relaterade metoder

Genererade från metodgrafen och visade som maskinföreslagna relationer – inga bevispåståenden härleds.

Taxonomic bucketAdaptive Randomized Clinical Trialmachine-suggested · Relational suggestion, not evidence.Same method familyDiagnostic Accuracy Study Designmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketDose-Response Analysismachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase I Clinical Trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase III clinical trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketRandomized clinical trialmachine-suggested · Relational suggestion, not evidence.